Which cancer types are checkpoint inhibitors relevant for? WHat are the exciting breakthroughs in the past few years
Checkpoint inhibitors are a type of immunotherapy that has shown remarkable results in treating several types of cancers in recent years. These drugs work by taking the 'brakes' off the immune system, allowing it to recognize and attack cancer cells more effectively.
According to the National Comprehensive Cancer Network (NCCN) guidelines and resources from the American Society of Clinical Oncology (ASCO), checkpoint inhibitors have demonstrated significant breakthroughs in the following cancer types:
-
Melanoma: Checkpoint inhibitors like pembrolizumab (Keytruda) and nivolumab (Opdivo) were the first to be approved for advanced melanoma and have greatly improved survival rates.
-
Non-Small Cell Lung Cancer (NSCLC): Drugs like pembrolizumab, nivolumab, and atezolizumab (Tecentriq) are now standard treatments for certain types of NSCLC.
-
Bladder Cancer: Atezolizumab and pembrolizumab are approved for locally advanced or metastatic bladder cancer.
-
Kidney Cancer: Nivolumab and ipilimumab (Yervoy) are used for advanced renal cell carcinoma.
-
Head and Neck Cancers: Pembrolizumab and nivolumab are options for recurrent or metastatic disease.
-
Hodgkin Lymphoma: Nivolumab and pembrolizumab are approved for classical Hodgkin lymphoma after other treatments fail.
-
Colorectal Cancer: Pembrolizumab and nivolumab are approved for certain metastatic colorectal cancers with specific biomarkers.
Some of the most exciting breakthroughs with checkpoint inhibitors in recent years include their expanded use in various cancer types, longer survival rates, and the potential for lower toxicity compared to traditional chemotherapy. However, it's important to note that checkpoint inhibitors may not be effective for all patients or all cancer types, and ongoing research is exploring ways to improve their efficacy and identify predictive biomarkers.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about General
- What are PARP inhibitors and who should take them
- What is the latest in breakthrough treatment for metastatic prostate CA
- What are the side effects of TKI inhibitors
- What is radiation therapy and what are the different types
- What are the latest treatment options for my cancer type
- Hi, Has anyone here been diagnosed with ovarian cancer, or had it in the past? How did it all go? How are you doing...
- Been in such excruciating pain for over 2 months. I was hospitalized for a few days. The neuroradiologist called...
- Experiencing side effects that I thought would get better after a few months from my chemo and radiation. Food not...